Contrast observation of optical coherence tomography angiography between neovascular age-related macular degeneration and myopic choroidal neovascularization before and after intravitreal anti-vascular endothelial growth factor treatment_Chinese Journal of Ocular Fundus Diseases

Authors：

Min Xiaoxue , Liu Yilin , Zhou Sirui , Mu Jia ,  Zhang Ming

Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu 610041, China;

Corresponding author：

Zhang Ming, Email: zhangmingscu@126.com

Keywords：

Wet macular degeneration; Choroidal neovascularization; Tomography, optical coherence; Angiogenesis inhibitors/therapeutic use; Antibodies, monoclonal/therapeutic use

DOI：

10.3760/cma.j.issn.1005-1015.2019.01.008

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To compare the features of OCT angiography (OCTA) between neovascular age-related macular degeneration (nAMD) and myopic choroidal neovascularization (mCNV) patients before and after intravitreal anti-VEGF treatment. Methods A prospective cohort study. Twenty-nine patients (37 eyes) with nAMD (19 males and 10 females, aged 68.20±8.76) and 31 patients (34 eyes) with mCNV (9 males and 22 females, aged 43.10±11.80, with the mean diopter of −9.71±1.20 D) from Department of Ophthalmology, West China Hospital of Sichuan University during May and December 2017 were included in this study. Ranibizumab or Conbercept (0.5 mg/0.05 ml) was intravitreally injected in all eyes. The patients were follow-up for 3−6 months. The OCTA was conducted before treatment and 1 day, 1 week, 1 month and 3−6 months after treatment. In order to ensure that the scanning position was the same, the tracking mode was adopted for each scanning. According to the OCTA images, the lesion area, parafoveal superficial vessel density and perfusion area were measured and analyzed contrastively between nAMD and mCNV patients. Results The mean lesion area before and 1 month after treatment in nAMD patients were 0.38±1.87 mm² and 0.06±0.12 mm², while in mCNV patients, those were 0.26±1.06 mm² and 0.03±0.05 mm², respectively. There were statistically significant differences (Z=4.181, 4.475; P＜0.001) in CNV lesion area before and 1 month after treatment between nAMD and mCNV patients. Compared with those before treatment, the absolute change (Z=1.853, P=0.064) and the percentage changes (t=2.685, P=0.010) of CNV lesion area 1 month after treatment in nAMD and mCNV patients show a statistical meaning. There were significantly decreases in both parafoveal superficial vessel density (F=8.997, P=0.003) and perfusion area (F=7.887, P=0.015) 3 months after treatment in nAMD patients, while decreases in parafoveal superficial vessel density (F=11.142, P=0.004) and perfusion area (F=7.662, P=0.013) could be detected 1 day after treatment in mCNV patients, before rising 1 month after treatment. Conclusions There are significantly differences in lesion area before and after the treatment of intravitreal anti-VEGF between nAMD and mCNV patients by OCTA examination. Moreover, the changes of both parafoveal superficial vessel density and perfusion area after anti-VEGF treatment are statistically different in two groups.

Citation： Min Xiaoxue, Liu Yilin, Zhou Sirui, Mu Jia, Zhang Ming. Contrast observation of optical coherence tomography angiography between neovascular age-related macular degeneration and myopic choroidal neovascularization before and after intravitreal anti-vascular endothelial growth factor treatment. Chinese Journal of Ocular Fundus Diseases, 2019, 35(1): 36-39. doi: 10.3760/cma.j.issn.1005-1015.2019.01.008 Copy

1.	Bressler NM. Age-related macular degeneration is the leading cause of blindness[J]. JAMA, 2004, 291(15): 1900-1901. DOI: 10.1001/jama.291.15.1900.
2.	Wong TY, Ferreira A, Hughes R, et al. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review[J]. Am J Ophthalmol, 2014, 157(1): 9-25. DOI: 10.1016/j.ajo.2013.08.010.
3.	Xu D, Dãvila JP, Rahimi M, et al. Long-term progression of type 1 neovascularization in age-related macular degeneration using optical coherence tomography angiography[J]. Am J Ophthalmol, 2018, 187: 10-20. DOI: 10.1016/j.ajo.2017.12.005.
4.	Cheng Y, Li Y, Huang X, Qu Y. Application of optical coherence tomography angiography to assess anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization[J/OL]. Retinal, 2017, 2017: E1[2017-12-18]. https://insights.ovid.com/crossref?an=00006982-900000000-96633. DOI: 10.1097/IAE.0000000000002005. [published online ahead of print].
5.	Amoaku WM, Chakravarthy U, Gale R, et al. Defining response to anti-VEGF therapies in neovascular AMD[J]. Eye, 2015, 29(6): 721-727. DOI: 10.1038/eye.2015.48.
6.	Miere A, Butori P, Cohen SY, et al. Vascular remodeling of choroidal neovascularization after anti-vascular endothelial growth factor therapy visualized on optical coherence tomography angiography[J/OL]. Retina, 2017, 2017: E1[2017-11-23]. https://insights.ovid.com/crossref?an=00006982-900000000-96687. DOI: 10.1097/IAE.0000000000001964. [published online ahead of print].
7.	Iafe NA, Phasukkijwatana N, Sarraf D. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration[J]. Dev Ophthalmol, 2016, 56: 45-51. DOI: 10.1159/000442776.
8.	Mastropasqua L, Toto L, Borrelli E, et al. Optical coherence tomography angiography assessment of vascular effects occurring after aflibercept intravitreal injections in treatment-naive patients with wet age-related macular degeneration[J]. Retina, 2017, 37(2): 247-256. DOI: 10.1097/IAE.0000000000001145.
9.	孙姣, 王艳玲, 王佳琳. 光相干断层扫描血管成像在近视中的应用研究进展[J]. 中华眼底病杂志, 2018, 34(1): 83-86. DOI: 10.3760/cma.j.issn.1005-1015.2018.01.025.Sun J, Wang YL, Wang JL. Advances of optical coherence tomography angiography in myopia[J]. Chin J Ocul Fundus Dis, 2018, 34(1): 83-86. DOI: 10.3760/cma.j.issn.1005-1015.2018.01.025.
10.	黎晓新, 石璇. 认识光相干断层扫描血管成像技术特色, 提升光相干断层扫描血管成像技术临床应用水平[J]. 中华眼底病杂志, 2017, 33(1): 3-6. DOI: 10.3760/cma.j.issn.1005-1015.2017.01.002.Li XX, Shi X. Clinical applications of optical coherence tomography angiography[J]. Chin J Ocul Fundus Dis, 2017, 33(1): 3-6. DOI: 10.3760/cma.j.issn.1005-1015.2017.01.002.
11.	Toto L, Borrelli E, Di A L, et al. Retinal vascular plexuses' changes in dry age-related macular degeneration, evaluated by means of optical coherence tomography angiography[J]. Retina, 2016, 36(8): 1566-1572. DOI: 10.1097/IAE.0000000000000962.
12.	Mo J, Duan A, Chan S, et al. Vascular flow density in pathological myopia: an optical coherence tomography angiography study[J/OL]. BMJ Open, 2017, 7(2): e013571[2017-02-03]. DOI: 10.1136/bmjopen-2016-013571.

1. Bressler NM. Age-related macular degeneration is the leading cause of blindness[J]. JAMA, 2004, 291(15): 1900-1901. DOI: 10.1001/jama.291.15.1900.
2. Wong TY, Ferreira A, Hughes R, et al. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review[J]. Am J Ophthalmol, 2014, 157(1): 9-25. DOI: 10.1016/j.ajo.2013.08.010.
3. Xu D, Dãvila JP, Rahimi M, et al. Long-term progression of type 1 neovascularization in age-related macular degeneration using optical coherence tomography angiography[J]. Am J Ophthalmol, 2018, 187: 10-20. DOI: 10.1016/j.ajo.2017.12.005.
4. Cheng Y, Li Y, Huang X, Qu Y. Application of optical coherence tomography angiography to assess anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization[J/OL]. Retinal, 2017, 2017: E1[2017-12-18]. https://insights.ovid.com/crossref?an=00006982-900000000-96633. DOI: 10.1097/IAE.0000000000002005. [published online ahead of print].
5. Amoaku WM, Chakravarthy U, Gale R, et al. Defining response to anti-VEGF therapies in neovascular AMD[J]. Eye, 2015, 29(6): 721-727. DOI: 10.1038/eye.2015.48.
6. Miere A, Butori P, Cohen SY, et al. Vascular remodeling of choroidal neovascularization after anti-vascular endothelial growth factor therapy visualized on optical coherence tomography angiography[J/OL]. Retina, 2017, 2017: E1[2017-11-23]. https://insights.ovid.com/crossref?an=00006982-900000000-96687. DOI: 10.1097/IAE.0000000000001964. [published online ahead of print].
7. Iafe NA, Phasukkijwatana N, Sarraf D. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration[J]. Dev Ophthalmol, 2016, 56: 45-51. DOI: 10.1159/000442776.
8. Mastropasqua L, Toto L, Borrelli E, et al. Optical coherence tomography angiography assessment of vascular effects occurring after aflibercept intravitreal injections in treatment-naive patients with wet age-related macular degeneration[J]. Retina, 2017, 37(2): 247-256. DOI: 10.1097/IAE.0000000000001145.
9. 孙姣, 王艳玲, 王佳琳. 光相干断层扫描血管成像在近视中的应用研究进展[J]. 中华眼底病杂志, 2018, 34(1): 83-86. DOI: 10.3760/cma.j.issn.1005-1015.2018.01.025.Sun J, Wang YL, Wang JL. Advances of optical coherence tomography angiography in myopia[J]. Chin J Ocul Fundus Dis, 2018, 34(1): 83-86. DOI: 10.3760/cma.j.issn.1005-1015.2018.01.025.
10. 黎晓新, 石璇. 认识光相干断层扫描血管成像技术特色, 提升光相干断层扫描血管成像技术临床应用水平[J]. 中华眼底病杂志, 2017, 33(1): 3-6. DOI: 10.3760/cma.j.issn.1005-1015.2017.01.002.Li XX, Shi X. Clinical applications of optical coherence tomography angiography[J]. Chin J Ocul Fundus Dis, 2017, 33(1): 3-6. DOI: 10.3760/cma.j.issn.1005-1015.2017.01.002.
11. Toto L, Borrelli E, Di A L, et al. Retinal vascular plexuses' changes in dry age-related macular degeneration, evaluated by means of optical coherence tomography angiography[J]. Retina, 2016, 36(8): 1566-1572. DOI: 10.1097/IAE.0000000000000962.
12. Mo J, Duan A, Chan S, et al. Vascular flow density in pathological myopia: an optical coherence tomography angiography study[J/OL]. BMJ Open, 2017, 7(2): e013571[2017-02-03]. DOI: 10.1136/bmjopen-2016-013571.

Chinese Journal of Ocular Fundus Diseases

Contrast observation of optical coherence tomography angiography between neovascular age-related macular degeneration and myopic choroidal neovascularization before and after intravitreal anti-vascular endothelial growth factor treatment

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content